Markets » Mutual Funds » Asset Allocation

Nippon India Pharma Fund (Bonus) - Scheme Profile

Fund

Fund House : Nippon India Mutual Fund

Fund Class : Equity - Pharma

NAV 05 Jun 2020 191.24 0.15
(0.08%)

Asset Type

Asset Allocation
Derivatives 0.05
Equity 96.48
Reverse Repo 3.89
Equity Sector No. of Shares Mkt Value % of Assets Stocks Return
Asset / Company Name     (Rs cr)   Last 3 Mths
Aurobindo Pharma Pharmaceuticals - Indian - Bulk Drugs & Fo... 5,000,000 312.92 10.98 41.27
Dr Reddy's Labs Pharmaceuticals - Indian - Bulk Drugs & Fo... 750,000 295.22 10.36 26.57
Sun Pharma.Inds. Pharmaceuticals - Indian - Bulk Drugs & Fo... 6,300,976 292.65 10.27 22.06
Divi's Lab. Pharmaceuticals - Indian - Bulk Drugs 1,100,075 256.64 9.00 10.58
Cipla Pharmaceuticals - Indian - Bulk Drugs & Fo... 3,800,000 224.05 7.86 47.83
Lupin Pharmaceuticals - Indian - Bulk Drugs 2,500,025 208.83 7.33 33.4
› More

Sector Allocation

You can check out the sectoral allocation of the investments made for that scheme by the mutual fund in this Piechart as on the date selected.

Sector Name
Healthcare 12.29
NA 3.94
Pharmaceuticals - Indian - Bulk Drugs 16.33
Pharmaceuticals - Indian - Bulk Drugs & Formln 58.73
Pharmaceuticals - Multinational 9.13

Top Holdings

You can check out the Top Holdings of the investments made for that scheme by the mutual fund in
this Piechart as on the date selected.

Company Name
Abbott India 4.36
Alkem Lab 3.57
Aurobindo Pharma 10.98
Biocon 4.36
Cadila Health. 3.97
Cipla 7.86
Divi's Lab. 9.00
Dr Reddy's Labs 10.36